SCHOLARLY PUBLICATION

Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Sorèze 2009

📖 Journal of the American Academy of Dermatology → 📅 2010-07-21 🔗 DOI: 10.1016/j.jaad.2009.11.020

View Journal Profile → View Official Paper ↗

📄 Abstract

The abstract has not yet been added. Use the official source link for the complete publication record.

ℹ️ Publication Details

Journal: Journal of the American Academy of Dermatology
Published: 2010-07-21
DOI: 10.1016/j.jaad.2009.11.020
OpenAlex: W2119155691
Access: Via publisher

📋 Cite This Paper

Vinzenz Oji, Gianluca Tadini, Masashi Akiyama, Claudine Blanchet Bardon, Christine Bodemer, Emmanuelle Bourrat, Philippe Coudiere, John J. DiGiovanna, Peter M. Elias, Judith Fischer, Philip H. Fleckman, Michal Gina, John I Harper, Takashi Hashimoto, Ingrid Haußer, Hans Christian Hennies, Daniel Hohl, Alain Hovnanian, Akemi Ishida‐Yamamoto, W.K. Jacyk, Sancy Ann Leachman, Irene M. Leigh, J. Mazereeuw‐Hautier, Leonard M. Milstone, Fanny Morice‐Picard, Amy S. Paller, Gabriele Richard, Matthias Schmuth, Hiroshi Shimizu, Eli Sprecher (2010). Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Sorèze 2009. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2009.11.020

📄 Abstract

🔬 Related Research Papers

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

Guidelines of care for the management of cutaneous squamous cell carcinoma

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

The burden of skin diseases: 2004

Wound healing and treating wounds

Guidelines of care for the management of psoriasis and psoriatic arthritis

Tetracyclines: Nonantibiotic properties and their clinical implications

Psoriasis prevalence among adults in the United States

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

Cutaneous squamous cell carcinoma